News Releases

Date	Title	Document
Date Oct 14, 2020	Title Oncocyte Announces New Prospective Data Demonstrating That Treatment Informed by DetermaRx™ Significantly Improves Lung Cancer Patient Survival	Document PDF
Date Oct 08, 2020	Title Oncocyte and Fondazione Michelangelo, a Leading Non-Profit Cancer Research Foundation, Announce Immune Therapy Biomarker Collaboration	Document PDF
Date Oct 01, 2020	Title Oncocyte Agrees to Enter Licensing and Collaboration Agreement with Chronix Biomedical	Document PDF
Date Sep 14, 2020	Title Oncocyte to Participate at the Lake Street Capital Markets 4th Annual Best Ideas Growth Conference	Document PDF
Date Sep 09, 2020	Title Oncocyte Receives Final Pricing Decision for DetermaRx™ Molecular Test for Lung Cancer from Centers for Medicare and Medicaid Services	Document PDF
Date Sep 03, 2020	Title Oncocyte and the Guardian Research Network® Announce Strategic Alliance	Document PDF
Date Aug 27, 2020	Title Oncocyte Announces Addition of Experienced Healthcare Executive, Jennifer Carter, MD, MPH, MBA to Board of Directors	Document PDF
Date Aug 13, 2020	Title Oncocyte to Participate at Needham Virtual Cancer Diagnostics Conference	Document PDF
Date Aug 11, 2020	Title Oncocyte to Hold KOL Webinar Highlighting Clinical Data on Its DetermaIO™ Test for Immunotherapy Response Prediction	Document PDF
Date Jul 29, 2020	Title Oncocyte Provides Corporate Update and Reports Second Quarter 2020 Financial Results	Document PDF